Assessment of metabolic viability of cryopreserved hepatocytes and liver microsomes using bufuralol as a model substrate

被引：0
|
作者：
Padrós, J [1 ]
Tran, PQ [1 ]
Daly, E [1 ]
Chun, D [1 ]
Flarakos, T [1 ]
机构：
[1] MDS Pharma Serv, Montreal, PQ H4R 2N6, Canada
来源：
DRUG METABOLISM REVIEWS | 2004年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
420
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [1] Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance
    Stringer, R.
    Nicklin, P. L.
    Houston, J. B.
    XENOBIOTICA, 2008, 38 (10) : 1313 - 1329
  • [2] Prediction of metabolic clearance using fresh human hepatocytes: Comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines
    Hallifax, D.
    Galetin, A.
    Houston, J. B.
    XENOBIOTICA, 2008, 38 (04) : 353 - 367
  • [3] Metabolic lability screen using cryopreserved hepatocytes
    Milbury, HL
    Bi, YA
    Duignan, DB
    DRUG METABOLISM REVIEWS, 2002, 34 : 200 - 200
  • [4] Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance
    Brown, Hayley S.
    Griffin, Michael
    Houston, J. Brian
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (02) : 293 - 301
  • [5] METABOLIC ACTIVATION OF DAPAGLIFLOZIN AND CANAGLIFLOZIN IN VITRO IN LIVER MICROSOMES AND HEPATOCYTES
    Grillo, Mark
    Thuy Tran
    Khera, Smriti
    DRUG METABOLISM REVIEWS, 2014, 45 : 196 - 197
  • [6] In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes
    Kim, H
    Yoon, YJ
    Kim, H
    Cha, EY
    Lee, HS
    Kim, JH
    Yi, KY
    Lee, S
    Cheon, HG
    Yoo, SE
    Lee, SS
    Shin, JG
    Liu, KH
    ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (11) : 1287 - 1292
  • [7] ASSESSMENT OF VIABILITY OF HEPATOCYTES IN SUSPENSION USING THE MTT ASSAY
    SCHILLER, CD
    KAINZ, A
    MYNETT, K
    GESCHER, A
    TOXICOLOGY IN VITRO, 1992, 6 (06) : 575 - 578
  • [8] In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes
    Hyojin Kim
    Yune -Jung Yoon
    Hyunmi Kim
    Eun -Young Cha
    Hye Suk Lee
    Jeong -Han Kim
    Kyu Yang Yi
    Sunkyung Lee
    Hyae Gyeong Cheon
    Sung -Eun Yoo
    Sang -Seop Lee
    Jae -Gook Shin
    Kwang -Hyeon Liu
    Archives of Pharmacal Research, 2005, 28 : 1287 - 1292
  • [9] IMPACT OF DONOR DIVERSITY ON PHASE I AND PHASE II ACTIVITIES IN CRYOPRESERVED HUMAN HEPATOCYTES AND HUMAN LIVER MICROSOMES
    Bohl, Christopher
    Brouwer, Kenneth
    Heyward, Scott
    Cottier, Karissa
    Noah, Courtney
    Ogilvie, Brian
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [10] Comparison of genistein metabolism in rats and humans using liver microsomes and hepatocytes
    Bursztyka, Julian
    Perdu, Elisabeth
    Tulliez, Jacques
    Debrauwer, Laurent
    Delous, Georges
    Canlet, Cecile
    De Sousa, Georges
    Rahmani, Roger
    Benfenati, Emilio
    Cravedi, Jean-Pierre
    FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (03) : 939 - 948
12345